N@N

CryoPort Systems, Inc.: CryoPort Data Logger Providing Proof of Temperature Integrity During Shipping

  //house-home.news-articles.net/content/2009/08/2 .. of-of-temperature-integrity-during-shipping.html
  Published in House and Home on Wednesday, August 26th 2009 at 6:30 GMT, Last Modified on 2009-08-26 06:30:05 by Market Wire
          ^{🞛 This publication is a summary or evaluation of another publication}

LAKE FOREST, CA--(Marketwire - August 26, 2009) - CryoPort Systems, Inc. (OTCBB: [ CYRX ]) today announced successful testing and implementation of an automated data logger that tracks the internal and external sample temperatures.

The data logger provides another enhancement to the CryoPort Express™ Shipping System that already has a significant advantage with its long holding times over short term dry ice shipments. By providing the temperature data during transport, customers can be assured that their samples will have arrived with constant temperatures during shipment. In addition, the long holding time of the CryoPort Express shipper of 10+ days of frozen integrity give this innovative solution a significant advantage of the standard today of dry ice.

Larry Stambaugh, CEO of CryoPort, stated, "We have been working with a well known biotechnology company on the application of the data logger and they have been extremely pleased with the results of its use. The ease and utility of this addition is a major improvement in the frozen shipping market."

Bret Bollinger, VP of Operations, stated, "The data logger provides us a unique tool that takes the safety and security of shipments to the next level. Customers will no longer have to rely on potentially inaccurate data from probes placed at several locations in a dry ice box. We believe that the integrity of our shipments are well maintained and can be proven."

About CryoPort, Inc.

CryoPort ([ www.cryoport.com ]) is commercializing proprietary, technology-driven shipping products for use in the rapidly growing global biotechnology and biopharmaceutical cold chain. The products developed by CryoPort are essential components of the infrastructure required for the clinical testing, research and end user deliver of temperature-sensitive medicines and biomaterials in an increasingly complex logistical environment.

SAFE HARBOR

This press release contains forward-looking statements. The words "estimate," "possible" and "seeking" and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.